Radiation Dose Management (RDM) Market Set for Prosperity in Future

1. Healthcare Why are Developed Regions Witnessing Robust Radiation Dose Management (RDM) Market Advance? © P&S Intelligence. All rights reserved Page 1

2. With the discovery of X-rays by German physicist Wilhelm Conrad Röntgen on November 8, 1895, the field of diagnostics transformed forever. Soon, it became the go-to technology for orthopedists to see the bones inside the flesh and detect anomalies. Now, though the technology helped, it also caused problems because of the ionizing radiation contained in these rays. In the 1990s, numerous radiation- related skin injuries were reported to the U.S. Food and Drug Administration (FDA), which led to the creation on a set of guidelines for managing the radiation given off by X-ray and fluoroscopy machines (which also use X-rays). Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/radiation- dose-management-market/report-sample These concerns regarding radiation sickness, which can result in common symptoms such as fainting, nausea, confusion, diarrhea, vomiting, mouth and skin sores, hair loss, and bleeding, and, in extreme cases, cancer, have birthed the radiation dose management (RDM) market, which is now growing steadily around the world. RDM is majorly done using computer software which track, study, and report data on the radiation being given off by various radiology machines. With further enhancements in technology, the data is now being stored and shared over cloud. Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry- url=radiation-dose-management-market Similarly, in July 2017, the U.S. Patent and Trademark Office granted a patent to the XR-29 Dose-Check system, which is offered under the SafeCT-29 software suite by Medic Vision. The software, developed in accordance with the NEMA XR-29 CT radiation dose management standards released by the American College of Radiology, has since been installed at numerous medical centers across the country. In the same vein, Medsquare has integrated VirtualDose CT, which is an organ dose module, with its dose archive and communication system (DACS), which is itself an RDM software. As most such solutions are being used in developed countries, due to the stricter guidelines there than in other nations, North America and Europe are currently the forerunners in the adoption of this concept. North America is presently the largest radiation dose management market, because a huge number of CT and X-rays are performed here on a daily basis, which automatically raises the risk of radiation overexposure. Since medical imaging is essential here, owing to the high prevalence of chronic diseases in the region, the RDM guidelines, especially those released by the FDA and Medical Imaging and Technology Alliance (MITA), are rather strict. © P&S Intelligence. All rights reserved Page 2

3. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved Page 3